Rentschler Biopharma completes acquisition of U.S. manufacturing site

InflaRx continues U.S. expansion with addition of New York City corporate office and addition of management

Verona Pharma appoints Kathleen Rickard, MD, as chief medical officer to lead late stage clinical development of RPL554

Atriva Therapeutics announces first closing of series A financing round